News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Posner Christopher
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,307 shares
@ $3.07, valued at
$13.2k
|
|
| 05/09/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,869 shares
@ $4.4, valued at
$17k
|
|
| 03/07/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 5,987 shares
@ $9.71, valued at
$58.1k
|
|
| 02/03/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,191 shares
@ $11.8, valued at
$49.5k
|
|
| 11/18/2022 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 14,470 shares
@ $11.13, valued at
$161.1k
|
|
| 04/05/2022 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,006 shares
@ $12.67, valued at
$25.4k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Posner Christopher (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 5,941 shares
@ $0
Granted 142,000 shares
@ $0
Granted 566,000 options to buy
@ $16.83, valued at
$9.5M
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Posner Christopher (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $15.819, valued at
$31.6k
|
|
| 06/08/2020 |
4
| Posner Christopher (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 7,200 shares
@ $0
Granted 10,800 options to buy
@ $15.62, valued at
$168.7k
|
|
| 06/06/2019 |
4
| Posner Christopher (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 9,000 options to buy
@ $20.44, valued at
$184k
|
|
| 08/06/2018 |
4
| Posner Christopher (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $17.94, valued at
$627.9k
|
|
|
|